Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
91.79
+2.45 (2.74%)
At close: Aug 13, 2025, 4:00 PM
91.23
-0.56 (-0.61%)
Pre-market: Aug 14, 2025, 8:31 AM EDT
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$435,129
Profits / Employee
-$93,258
Market Cap
5.26B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GKOS News
- 1 day ago - Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
- 14 days ago - Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Glaukos Announces Second Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - Business Wire
- 7 weeks ago - Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - Business Wire
- 7 weeks ago - Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Business Wire
- 3 months ago - Glaukos Announces Participation in Upcoming Investor Conferences - Business Wire
- 3 months ago - Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript - Seeking Alpha